| Literature DB >> 27771208 |
Erin H Graf1, Maria Victoria Farquharson2, Ana María Cárdenas3.
Abstract
We compared an FDA cleared molecular meningitis/encephalitis panel to lab developed viral PCRs and bacterial culture. Of the 67 viral PCR or bacterial culture-positive samples, 92.5% were positive for the same target by the panel. Of the 66 negative samples tested, no targets were detected by the panel, for an agreement of 96.2%.Entities:
Keywords: Encephalitis; Meningitis; Molecular Panel
Mesh:
Year: 2016 PMID: 27771208 DOI: 10.1016/j.diagmicrobio.2016.09.022
Source DB: PubMed Journal: Diagn Microbiol Infect Dis ISSN: 0732-8893 Impact factor: 2.803